The diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeldt-Jakob disease;Utilidad diagnostica de la determinacion de la proteina 14-3-3 en el liquido cefalorraquideo en la enfermedad de Creutzfeldt-Jakob

Neurologia

Volumn 13, Issue 7, 1998, Pages 324-328

  Saiz A ^a   Marin C ^a   Tolosa, E ^a   Graus, F ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

14 3 3 brain protein; Cerebrospinal fluid; Creutzfeldt Jakob disease; Prion diseases; Spongiform encephalopaties

Indexed keywords

BRAIN PROTEIN; PROTEIN; PROTEIN 14 3 3; TYROSINE 3 MONOOXYGENASE;

ADULT; ARTICLE; BRAIN BIOPSY; BRAIN SPONGIOSIS; CEREBROSPINAL FLUID ANALYSIS; CODON; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC VALUE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRION DISEASE; PROTEIN DETERMINATION; CEREBROSPINAL FLUID; DIFFERENTIAL DIAGNOSIS; GENETICS; POINT MUTATION; RETROSPECTIVE STUDY;

14-3-3 PROTEINS; CODON; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; POINT MUTATION; PROTEINS; RETROSPECTIVE STUDIES; TYROSINE 3-MONOOXYGENASE;

EID: 0032135738     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prusiner SB, Hsiao KH. Human prion diseases. Ann Neurol 1994; 35: 385-395.
2. Haywood AM. Transmissible spongiform encephalopathies. N Engl J Med 1997; 337: 1.821-1.828.
3. Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986; 20: 597-602.
4. Harrington MG, Merril CR, Asher DM, Gajdusek DC. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 1986; 315: 279-283.
5. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335: 924-930.
6. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4.350-4.354.
7. Greenberg SM, Vonsattel JPG, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993; 43: 2.073-2.079.
8. Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O et al. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology 1997; 49: 593-595.
9. Zerr I, Bodemer M, Otto M, Poser S, Windl O, Kretzschmar HA et al. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996; 348: 846-849.
10. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43: 32-40.
11. Will RG, Zeidler M, Brown P, Harrington M, Lee KH, Kenney KL. Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease. Lancet 1996; 348: 955.
12. Zeidler M, Stewart GE, Barraclough CR, Bateman DE, Bates D, Burn DJ et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 1997; 350: 903-907.
13. Boston PF, Jackson P, Thompson RJ. Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J Neurochem 1982; 38: 1.475-1.482.
14. Martin H, Rostas J, Patel Y, Aitken A. Subcellular localization of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 1994; 63: 2.259-2.265.
15. Broadie K, Rushton E, Skoulakis EMC, Davis RL. Leonardo, a drosophila 14-3-3 protein involved in learning, regulates presynaptic function. Neuron 1997; 19: 391-402.